Interim [¹⁸F]fluorodeoxyglucose positron emission tomography imaging in stage I–II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?

Lale KostakogluMount Sinai School of Medicine, New York, NY, USACorrespondence[email protected]

Heiko SchöderMemorial Sloan-Kettering Cancer Center, New York, NY, USA

Jeffrey L. JohnsonCALGB Statistical Center, Duke University Medical Center, Durham, NC, USA

Nathan C. HallThe Ohio State University Medical Center, Columbus, OH, USA

Lawrence H. SchwartzColumbia University Medical Center, New York, NY, USA

David J. StrausMemorial Sloan-Kettering Cancer Center, New York, NY, USA

Ann S. LaCasceDana-Farber/Partners Cancer Care, Brigham and Women's Hospital, Boston, MA, USA

Sin-Ho JungCALGB Statistical Center, Duke University Medical Center, Durham, NC, USA

Nancy L. BartlettWashington University School of Medicine, St Louis, MO, USA

George P. CanellosDana-Farber/Partners Cancer Care, Brigham and Women's Hospital, Boston, MA, USA

Bruce D. ChesonGeorgetown University Hospital, Washington, DC, USA

Your download is now in progress and you may close this window